Journal Article DZNE-2020-05879

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2017
Wiley-Liss New York, NY [u.a.]

Human mutation 38(11), 1511-1520 () [10.1002/humu.23306]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Metachromatic leukodystrophy (MLD) is an autosomal-recessive lysosomal storage disease caused by mutations in the ARSA gene leading to arylsulfatase A (ARSA) deficiency and causing sulfatide accumulation. Main symptoms of the disease are progressive demyelination, neurological dysfunction, and reduced life expectancy. To date, more than 200 different ARSA variants have been reported in MLD patients. Here, we report the biochemical characterization of seven novel pathogenic variants (c.98T > C, c.195delC, c.229G > C, c.545C > G, c.674A > G, c.852T > A, and c.1274A > G), which were found when sequencing a cohort of 31 German MLD families. For that purpose, the ARSA cDNAs carrying the respective mutations inserted by site-directed mutagenesis were cloned into a MigR1 (MSCV, IRES, GFP, retrovirus-1) vector. The constructs were overexpressed using retroviral gene transfer in immortalized, human multipotent mesenchymal stromal cells prepared from a patient deficient in ARSA activity (late infantile MLD). In this novel ARSA-/- cell system, the seven ARSA mutants showed ARSA activity of less than 10% when compared with wild type, which is evidence for the pathogenicity of all seven variants. In conclusion, the system of ARSA-/- -immortalized MSC turned out to be a helpful novel tool for the biochemical characterization of ARSA variants.

Keyword(s): Adolescent (MeSH) ; Alleles (MeSH) ; Cell Line, Transformed (MeSH) ; Cerebroside-Sulfatase: genetics (MeSH) ; Cerebroside-Sulfatase: metabolism (MeSH) ; Child (MeSH) ; DNA Mutational Analysis (MeSH) ; Enzyme Activation (MeSH) ; Exons (MeSH) ; Female (MeSH) ; Flow Cytometry (MeSH) ; Gene Expression (MeSH) ; Genetic Variation (MeSH) ; Genotype (MeSH) ; Humans (MeSH) ; Immunophenotyping (MeSH) ; Leukodystrophy, Metachromatic: diagnosis (MeSH) ; Leukodystrophy, Metachromatic: enzymology (MeSH) ; Leukodystrophy, Metachromatic: genetics (MeSH) ; Male (MeSH) ; Mesenchymal Stem Cells: enzymology (MeSH) ; Mutagenesis, Site-Directed (MeSH) ; Mutation (MeSH) ; Open Reading Frames (MeSH) ; Plasmids: genetics (MeSH) ; Young Adult (MeSH) ; Cerebroside-Sulfatase

Classification:

Contributing Institute(s):
  1. Clinical Neurogenetics (AG Schöls)
Research Program(s):
  1. 345 - Population Studies and Genetics (POF3-345) (POF3-345)

Appears in the scientific report 2017
Database coverage:
Medline ; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > TÜ DZNE > TÜ DZNE-AG Schöls
Public records
Publications Database

 Record created 2020-02-18, last modified 2024-04-15


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)